NASDAQ · Biotechnology
Immunic Inc (IMUX)
$6.99
-5.41%
45
In band
Moving averages
SMA 200$11.55-39.48%
Company profile
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune and inflammatory diseases. The company is headquartered in New York, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$106.29M
P/E ratioNone
EPS$-3.83
Beta1.483
Dividend yield0.00%
52-week high$17.43
52-week low$5.06
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
SAVA
Cassava Sciences Inc
CHRS
Coherus Biosciences Inc
RSI 24
NERV
Minerva Neurosciences Inc
RSI 36
HRTX
Heron Therapeutics Inc
RSI 39
IVVD
Invivyd Inc
RSI 30
CGTX
Cognition Therapeutics Inc
RSI 29
RSI alerts for IMUX
An email when IMUX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 6:01 AM EST